Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

101.61
-0.4650-0.46%
Post-market: 101.610.00000.00%16:44 EDT
Volume:1.09M
Turnover:110.70M
Market Cap:25.52B
PE:-13.07
High:103.00
Open:102.01
Low:100.84
Close:102.08
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:0.60
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.24
PE(LYR):-18.41

Loading ...

Press Release: Andreas P. Stöcklin Appointed to Lead FTI Consulting's Transactions Offering in Continental Europe

Dow Jones
·
May 19

European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading

MT Newswires Live
·
May 18

BioNTech held annual general meeting; shareholders approved all agenda items

Reuters
·
May 16

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026

GlobeNewswire
·
May 16

CANCOM SE (0O0F) Gets a Hold from Berenberg Bank

TIPRANKS
·
May 14

Shionogi Covid Pill Reduced Infection Risk in Late-Stage Study

MT Newswires Live
·
May 14

Firebrick Pharma wins Canadian patent for Nasodine COVID-19 use

TIPRANKS
·
May 13

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX), Personalis (PSNL) and Alpha Tau Medical Ltd (DRTS)

TIPRANKS
·
May 12

Berenberg Lowers Price Target on BioNTech to $140 From $155, Keeps Buy Rating

MT Newswires Live
·
May 12

Chuck Schumer Sounds Alarm On Hantavirus Threat, Says Trump 'Didn't Learn The Lesson From COVID-19'

Benzinga_recent_news
·
May 12

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Siemens Healthineers AG (OtherSEMHF) and BioNTech SE (BNTX)

TIPRANKS
·
May 12

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

GlobeNewswire
·
May 11

BioNTech Approves $1 Billion ADS Repurchase Program

MT Newswires Live
·
May 07

BioNTech launches new ADS buyback program worth up to USD 1 billion

Reuters
·
May 07

BioNTech Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 07

BioNTech Maintained at Buy as Oncology Momentum Builds and Upside Seen at Unchanged $128 Price Target

TIPRANKS
·
May 07

BioNTech SE (BNTX) Receives a Buy from Goldman Sachs

TIPRANKS
·
May 06

German Government Spokesperson: Loss of BioNTech Vaccine Production Can Be Offset by Other Companies

THOMSON REUTERS
·
May 06

German Government Spokesperson: Decision by BioNTech Regarding Locations in Germany Is Business Decision; We Will Not Comment on the Specifics

THOMSON REUTERS
·
May 06

PRESS DIGEST-Financial Times - May 6

Reuters
·
May 06